NRBO Projected Dividend Yield
Com Par $0.001/NeuroBo Pharmaceuticals Inc ( NASDAQ : NRBO )NeuroBo Pharmaceuticals is a clinical-stage biotechnology company focused primarily on developing and commercializing pharmaceuticals to treat cardiometabolic diseases. Co. has two primary programs focused on treatment of nonalcoholic steatohepatitis (NASH), obesity and type 2 diabetes (T2D): DA-1241, which is a G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; as well as DA-1726, which is an oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity that is to be administered once weekly subcutaneously. 20 YEAR PERFORMANCE RESULTS |
NRBO Dividend History Detail NRBO Dividend News NRBO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |